The specificity of this anti-tumor response was established by showing that mice immunized with recMAGE+AS15 were not able to eradicate TC1 cells transfected with an irrelevant antigen (TC1-Her2/neu) injected in the same conditions as the TC1-MAGE-A3 cells (data not shown). This evidence concerns the gene ERBB2 and neoplasm.